Niraparib exhibits a synergistic anti-tumor effect with PD-L1 blockade by inducing an immune response in ovarian cancer

Jinyu Meng(Shandong University), Beihua Kong(Qilu Hospital of Shandong University)
Journal of Translational Medicine
October 7, 2021
Cited by 60


Related Papers